Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.50) per share. This is a 16.28 percent decrease over losses of $(0.43) per share from the same period last year.
HeartCore Enterprises Earnings Perspective: Return On Capital Employed
According to Benzinga Pro, during Q1, HeartCore Enterprises (NASDAQ:HTCR) earned $1.81 million, a 226.93% increase from the preceding…